Britannia Pharmaceuticals Limited

Britannia Pharmaceuticals Limited, located in the South of England, is a niche pharmaceutical company specialising in products for diseases with orphan indications (small patient populations) which are normally not developed by larger pharmaceutical companies. It is our primary focus to search for and develop pharmaceutical products for special patient groups, expanding our know-how in the disease areas our products serve, and to make these products available internationally.
The company has built its success and ability to develop active compounds into fully licensed pharmaceutical preparations, with particular expertise in clinical trials, formulation work, registration, marketing and sales.
Our primary expertise is in the development of products for the areas of Parkinson's disease and opiate detoxification. We have been active with UK neurologists and geriatricians since 1981, starting with the marketing and development of the product Eldepryl (selegiline hydrochloride). These relationships helped us to identify the benefit of and need for apomorphine as a rescue treatment for Parkinson's disease sufferers, leading to the development of our APO-go products

Contact Details: 41-51 Brighton Road Redhill Surrey RH1 6YS United Kingdom Tel: (+44) 01737 773741 Fax: (+44) 01737 762672 Email: WWW: www.britannia-pharm.co.uk/

Loading...

Recent Publications by Britannia Pharmaceuticals Limited:
Lofexidine in opiate withdrawal: a safety and usage survey. A retrospective, observational survey, conducted under the remit of the...	26th November, 2008	Britannia Pharmaceuticals Limited, Redhill, Surrey, UK.	Pharmacoepidemiol Drug Saf. 2000 Jan;9(1):43-7. DOI Direct Link

Britannia Pharmaceuticals Limited Clinical Trials:
Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.

Britannia Pharmaceuticals Limited Patents:
US Patent No.	Title
7473416	Medicaments for asthma treatment
7273604	Anti-asthmatic combinations comprising surface active phospholipids
6824761	Anti-asthmatic combinations comprising surface active phospholipids
6719960	Use of phospholipids for the manufacture of a medicament for the prevention of adhesions
6482391	Medicaments for asthma treatment
→View more Britannia Pharmaceuticals Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 565 times since April 2007, the link to the organisation's website has been followed 83 times

Recent Search Terms used to find this page: britannia pharmaceutical contact details | Britannia Drug company jobs | britannia pharmaceuticals redhil address | Britannia Pharmaceuticals | britannia pharmaceuticals | Britannia Pharmaceuticals | britannia pharmaceuticals redhill surrey | britannia pharmaceuticals | Britannia Pharmaceuticals address | britannia pharmaceuticals sureey | .

Search for more companies in Redhill

Search for more companies in Surrey

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Britannia Pharmaceuticals Limited